1 active not recruiting, 1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Appendix Adenocarcinoma: new trials by email Literature Review of Appendix Adenocarcinoma trials Research Report on Appendix Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Genetics of Appendix Cancer Study Genetic profiling, Retrospective tissue procurement - Appendix Cancer, Appendiceal Cancer | Recruiting | Andreana Holowatyj, PhD, MSCI | 700 | 2022-11-11 | 2025-04-18 | |
| Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors Atezolizumab, Cobimetinib - Skin Squamous Cell Carcinoma, Appendix Adenocarcinoma | Phase 2 | Completed | M.D. Anderson Cancer Center | 49 | 2017-04-07 | 2025-05-28 |
| Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors Atezolizumab, Bevacizumab, Laboratory Biomarker Analysis - Appendix Adenocarcinoma, Human Papillomavirus-Related Anal Squamous Cell Carcinoma | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 133 | 2017-03-03 | 2026-09-14 |
Adenocarcinoma, Mucinous (3) · Adenoma, Islet Cell (1) · Appendiceal Neoplasms (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Neuroendocrine (1) · Mesothelioma, Malignant (1) · Nasopharyngeal Carcinoma (1) · Nasopharyngeal Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1)
Adenocarcinoma (3) · Carcinoma (3) · Neoplasms by Histologic Type (3) · Neoplasms, Cystic, Mucinous, and Serous (3) · Neoplasms, Glandular and Epithelial (3) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Adenoma (1) · Cecal Diseases (1) · Cecal Neoplasms (1) · DNA Virus Infections (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1)
atezolizumab (2) · Bevacizumab (1) · DNA Fingerprinting (1) · Disulfides (1) · Immunoglobulin G (1) · cobimetinib (1)
M.D. Anderson Cancer Center (2) · Andreana Holowatyj, PhD, MSCI (1)
United States (3)
Andreana N Holowatyj, PhD, MSCI (1) · Kanwal P Raghav (1) · Kanwal P Raghav, MD (1)